These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6322365)

  • 1. Effects of chronic naltrexone on amphetamine locomotor activity.
    Ng Cheong Ton MJ; Blair R; Holmes L; Amit Z
    Subst Alcohol Actions Misuse; 1983; 4(4):331-6. PubMed ID: 6322365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chronic prenatal and postnatal administration of naltrexone in locomotor activity induced by morphine in mice.
    Medina Jiménez M; Luján Estrada M; Rodríguez R
    Arch Med Res; 1997; 28(1):61-5. PubMed ID: 9078589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat.
    Häggkvist J; Lindholm S; Franck J
    Addict Biol; 2009 Jul; 14(3):260-9. PubMed ID: 19298318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of opioid receptor antagonists on motor-impairing effects of benzodiazepines.
    Fidecka S; Langwiński R
    Pol J Pharmacol; 2000; 52(3):187-93. PubMed ID: 11055575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists.
    Iwamoto ET
    J Pharmacol Exp Ther; 1981 May; 217(2):451-60. PubMed ID: 6262485
    [No Abstract]   [Full Text] [Related]  

  • 6. Different effects of chronic exposure to ELF magnetic field on spontaneous and amphetamine-induced locomotor and stereotypic activities in rats.
    Janać B; Pesić V; Jelenković A; Vorobyov V; Prolić Z
    Brain Res Bull; 2005 Nov; 67(6):498-503. PubMed ID: 16216699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
    Wunderlich GR; Rotzinger S; Bush DE; DeSousa NJ; Vaccarino FJ
    Brain Res; 2004 Mar; 1001(1-2):95-107. PubMed ID: 14972658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
    Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
    Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acute treatment with amphetamine in locomotor activity in sepsis survivor rats.
    Comim CM; Constantino LS; Petronilho F; de Souza B; Barichello T; Quevedo J; Dal-Pizzol F
    J Neuroimmunol; 2009 Jul; 212(1-2):145-7. PubMed ID: 19423170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of repeated exposure to toluene or amphetamine on locomotor activity in rats.
    Wiaderna D; Tomas T
    Int J Occup Med Environ Health; 2000; 13(4):317-24. PubMed ID: 11276845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine and stress responses in developmentally lead-exposed rats.
    Virgolini MB; Volosin M; Fulginiti AS; Cancela LM
    Neurotoxicol Teratol; 2004; 26(2):291-303. PubMed ID: 15019963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat.
    Kimmel HL; Holtzman SG
    J Pharmacol Exp Ther; 1997 Aug; 282(2):734-46. PubMed ID: 9262337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone and naltrexone: actions and interactions at an opiate drug receptor on frog skeletal muscle fibers.
    Frank GB; Marwaha J
    J Pharmacol Exp Ther; 1979 Jun; 209(3):382-8. PubMed ID: 220407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in locomotor activity during chronic cocaine administration: effect on dopamine receptors and interaction with opioids.
    Kunko PM; French D; Izenwasser S
    J Pharmacol Exp Ther; 1998 Apr; 285(1):277-84. PubMed ID: 9536022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naloxone and naltrexone on locomotor activity in C57BL/6 and DBA/2 mice.
    Castellano C; Puglisi-Allegra S
    Pharmacol Biochem Behav; 1982 Apr; 16(4):561-3. PubMed ID: 6280203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of ethanol effects by opiate antagonists.
    Harris RA; Erickson CK
    Curr Alcohol; 1979; 5():17-28. PubMed ID: 755620
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
    Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
    Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine treatment produces persistent increases in amphetamine-stimulated locomotor activity in periadolescent male but not female or adult male rats.
    Collins SL; Montano R; Izenwasser S
    Brain Res Dev Brain Res; 2004 Nov; 153(2):175-87. PubMed ID: 15527885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.